Novel isatin conjugates endowed with analgesic and anti-inflammatory properties: design, synthesis and biological evaluation
Future Medicinal Chemistry · 2025
DOI: 10.1080/17568919.2024.2437981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2025. Verfasst von LaVauria D Brown und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Augusta University, Augusta, GA, USA. Hauptthemen laut MEDLINE: Isatin, Analgesics, Drug Design, Molecular Docking Simulation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Augusta University.
Abstract (Originalsprache)
AIMS: This study aimed to develop novel molecular hybrid conjugates integrating isatin, rhodanine, and phthalimide pharmacophores to create effective analgesic and anti-inflammatory agents with improved safety profiles over existing treatments. MATERIALS & METHODS: A series of hybrid conjugates (4a - l) were synthesized and evaluated through in vitro and in vivo biological assays. The most promising compound, 4c, underwent extensive pharmacological and toxicological evaluations. Molecular docking, molecular dynamics simulations, and 2D-QSAR studies were performed to elucidate the mechanism of action and validate the experimental findings. RESULTS: Compound 4c exhibited potent analgesic and anti-inflammatory activity, effectively inhibiting COX-2 and pro-inflammatory cytokines (IL-6 and TNF-α). Its superior selectivity index (SI) was 1.11 compared to 0.67 for indomethacin. It demonstrated an ulcer index of 2.9 versus 10.23 for indomethacin, indicating reduced gastrointestinal toxicity. Molecular docking simulations revealed a strong binding affinity with COX-2 (-9.832 kcal/mol), and molecular dynamics confirmed the stability of the COX-2 complex. CONCLUSIONS: Compound 4c emerged as a promising lead candidate for developing safer and more effective anti-inflammatory and analgesic agents. Its robust efficacy, safety profile, and computational validation highlight its potential for further optimization in therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Augusta University, Augusta, GA, USA.
- Department of Pesticide Chemistry, National Research Centre, Giza, Egypt.
- Department of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, USA.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Pharmaceutical Engineering & Technology Indian Institute of Technology, Banaras Hindu University, Varanasi, UP, India.
ORCID-Profile: LaVauria D Brown, Adel S Girgis, Siva S Panda
Förderung
- Augusta University
Zitieren
APA
Brown, L. D., Girgis, A. S., Patel, S., Samir, N., Said, M. F., Baidya, A. T. K., Kumar, R., Moore, J., Khadanga, A., Sakhuja, R., & Panda, S. S. (2025). Novel isatin conjugates endowed with analgesic and anti-inflammatory properties: design, synthesis and biological evaluation. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2024.2437981
Vancouver
Brown LD, Girgis AS, Patel S, Samir N, Said MF, Baidya ATK, et al. Novel isatin conjugates endowed with analgesic and anti-inflammatory properties: design, synthesis and biological evaluation. Future Medicinal Chemistry. 2025. doi:10.1080/17568919.2024.2437981
BibTeX
@article{Brown2025,
author = {Brown, LaVauria D and Girgis, Adel S and Patel, Shruti and Samir, Nermin and Said, Mona F and Baidya, Anurag T K and Kumar, Rajnish and Moore, Jade and Khadanga, Anshuman and Sakhuja, Rajeev and Panda, Siva S},
title = {Novel isatin conjugates endowed with analgesic and anti-inflammatory properties: design, synthesis and biological evaluation},
journal = {Future Medicinal Chemistry},
year = {2025},
doi = {10.1080/17568919.2024.2437981}
}
EUVIMED